Covectra Offers Solutions to Secure Drug Supply Chain

Covectra (Southborough, MA) announces the availability of technology solutions to support pharmaceutical companies in quickly responding to an FDA guideline issued last week, which relates to regulatory standards in developing a secure pharmaceutical supply chain.


In addition to offering affordable solutions for FDA’s suggested guidance that all pharmaceutical companies print Standardized Numerical Identification codes on all secondary packaging, Covectra uniquely provides unit-dose identification technology that further secures prescription drugs and medical devices traveling through the complex supply chain to consumers, making each pill or medical device verifiable as an authentic product.

In an effort to contribute to anti-counterfeiting initiatives in the United States, as the first of several guidances and regulations that FDA plans to issue and implement, the “Standards for Securing the Drug Supply Chain – Standardized Numerical Identification (SNI) for Prescription Drug Packages” <> document indicates that standards must be developed for identification, validation, authentication, and tracking and tracing of prescription drugs. It also recommends that an SNI be applied to a prescription drug at the point of manufacturing and repackaging, at the package or pallet level.


This SNI, which should be applied to each new package in both human-readable and machine-readable forms, will be linked back to the manufacturer’s SNI for the container. In this document, the FDA recommends specifically that the SNI for most prescription drug packages should be a serialized National Drug Code (sNDC) that corresponds to the specific drug product combined with a unique serial number, generated by the manufacturer or re-packager for each individual package, which should have no more than 20 characters.

Covectra offers pharmaceutical manufacturers the technology to support these newly identified standards, while also providing the ability to apply even more significant security and integrity measures which uniquely allow traceability down to the unit and dosage level. Covectra’s security offerings are applied in layers, from simple labels and cartons with proprietary taggants, to sophisticated web-based serialization solutions that provide the brand with “end-to-end” knowledge of the product’s life history and disposition. By combining these various layers of security, a product travels from manufacturing, through packaging, into distribution through multiple wholesalers, to the retailer’s point of sale, and into the hands of the consumer with maximum traceability, safety and integrity.


“With up to 90% of Internet drug sites selling adulterated drugs, diversion control and counterfeiting are concerns that substantially impact the pharma industry,” says Steve Wood, president and CEO, Covectra. “With applications providing the opportunity for traceability throughout the supply chain, manufacturers, customs officials and law enforcement can identify counterfeit and diverted product and detect how and where the product entered the supply chain.”

The Covectra methodology creates a sophisticated, streamlined capability to identify and prevent product diversion and counterfeiting, which, coupled with its AuthentiTrack software platform, provides a complete portfolio of software and packaging security solutions to protect as well as enhance consumer loyalty to any valuable brand. Additionally, the companies’ unique smartphone application can application can be used to input serialized human readable codes that are unique to a unit package. Once the code is entered into the smartphone, the application checks it against Covectra's AuthentiTrack software platform which can be used to track the product through all levels of distribution from the point of packaging throughout the supply chain, and ultimately to the consumer. The consumer is then able to verify authenticity, communicate directly with the manufacturer, and enroll in product promotions programs.

No votes yet